Important issues in the cytotoxicity screening of nano-sized materials

Open access

Abstract

Due to their extraordinary properties nano-sized materials (NMs) are increasingly used in industrial, pharmaceutical and medical applications. An even broader use is currently limited by concern about their potential adverse effect on health. Screening for toxic effects of all engineered NMs therefore, is needed to demonstrate biocompatibility. The identification of adverse cellular effects is one of the first steps in the toxicological assessment of drug compounds before they get to the market. A panel of cytotoxicity screening assays is available and can be used also for the assessment of NMs. The use of these established and validated assays for the testing of NMs, however, is complicated by the fact that NMs may interfere by color, chemical reactivity and light scattering leading to false positive or false negative results. The paper illustrates the principles of conventional cytotoxicity screening assays and discusses their suitability for the assessment of NMs. Adequate controls to identify interference and alternatives, if interference with the used assay is seen, are suggested.

1. Nel A, Xia T, Madler L, Li N 2006 Toxic potential of materials at the nanolevel. Science 311:622-627.

2. Vistejnova L, Dvorakova J, Hasova M, Muthny T, Velebny V, Soucek K, Kubala L 2009 The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. Neuro Endocrinol Lett 30 Suppl 1:121-127.

3. Petty R, Sutherland L, Hunter E, Cree I 1995 Comparison of MTT and ATP-based assays for the measurement of viable cell number. J Biolum Chemolum 10:29-34.

4. Shrivastava R, Delomenie C, Chevalier A, John G, Ekwall B, Walum E, Massingham R 1992 Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals. Cell Biol Toxicol 8:157-170.

5. Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lyng FM 2007 In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol In Vitro 21:438-448.

6. Isobe H, Tanaka T, Maeda R, Noiri E, Solin N, Yudasaka M, Iijima S, Nakamura E 2006 Preparation, purification, characterization, and cytotoxicity assessment of water-soluble, transition-metal-free carbon nanotube aggregates. Angew Chem Int Ed Engl 45:6676-6680.

7. Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P 2007 The reliability and limits of the. MTT conversion test for carbon nanotubes - cell interaction. Carbon 45:2643-2648.

8. Monteiro-Riviere NA, Inman AO, Zhang LW 2009 Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222-235.

9. Stone V, Johnston H, Schins RP 2009 Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613-626.

10. Casey A, Herzog E, Davoren M, Lyn F, Bryne H, Chambers G 2007 Spectroscopic analysis confirms the interaction between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45:1425-1432.

11. Zhang LW, Zeng L, Barron AR, Monteiro-Riviere NA 2007 Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int J Toxicol 26:103-113.

12. Sabatini C, Pereira R, Gehlen M 2007 Fluorescence modulation of acridine orange and coumarin dyes by silver nanoparticles. J. Fluoresc 17:377-382.

13. Hurt RH, Monthioux M, Kane A 2006 Toxicology of carbon nanomaterials: Status, trends, and perspectives on the special issue. Carbon 44:1028-1033.

14. Hasnat MA, Uddin MM, Samed AJ, Alam SS, Hossain S 2007 Adsorption and photocatalytic decolorization of a synthetic dye erythrosine on anatase TiO2 and ZnO surfaces. J Hazard Mater 147:471-477.

15. Doak S, Griffiths S, Manshian B, Singh N, Williams P, Brown A, Jenkins G 2009 Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285-293.

16. Schrand AM, Huang H, Carlson C, Schlager JJ, Omacr Sawa E, Hussain SM, Dai L 2007 Are diamond nanoparticles cytotoxic? J Phys Chem B 111:2-7.

17. Gonzales M, Mitsumori LM, Kushleika JV, Rosenfeld ME, Krishnan KM 2010 Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127. Contrast Media Mol Imaging 5:286-293.

18. Casey A, Herzog E, Lyng FM, Byrne HJ, Chambers G, Davoren M 2008 Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. Toxicol Lett 179:78-84.

19. Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, Guerin M 2009 Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol In Vitro 23:697-703.

20. Worle-Knirsch JM, Pulskamp K, Krug HF 2006 Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6:1261-1268.

21. Kroll A, Pillukat MH, Hahn D, Schnekenburger J 2009 Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 72:370-377.

22. Spohn P, Hirsch C, Hasler F, Bruinink A, Krug HF, Wick P 2009 C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays. Environ Pollut 157:1134-1139.

23. Geys J, Nemery B, Hoet PH 2010 Assay conditions can influence the outcome of cytotoxicity tests of nanomaterials: better assay characterization is needed to compare studies. Toxicol In Vitro 24:620-629.

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 248 244 15
PDF Downloads 41 40 5